Learn about our latest activities
NOVAST Events
Publication
Announcement
Five Products are Approved by US FDA
Five NOVAST products (MELAMISA™, HER STYLE™, LERIBANE™, Nifedipine ER Tablets and Acetazolamide ER Tab....
2016-12-24
The Fourth Successful US FDA Inspection with ZERO 483 Observations
FDA investigator completes the fourth inspection from April 11th to April 15th, 2016 at NOVAST covering the following th....
2016-04-20
Another New Product gets Approval by US FDA
LARIN™ 24 Fe, a new product developed by NOVAST, receives approval from the US FDA in 2015.
2015-09-18
The Third Successful US FDA cGMP Inspection with ZERO 483 Observations
the Third Successful US FDA cGMP Inspection with ZERO 483 Observations occurred from June 1st to June 5th, 2015.
2015-06-18
Three More Products are Approved by US FDA
Three NOVAST products (LARIN™ 1.5/30, SETLAKIN™ and YAELA™) receive approval from the US FDA in 2014.
2014-12-25
Seven Products are Approved by US FDA
Seven NOVAST products (JULEBER™, PIMTREA™, LARIN™ FE 1.5/30, LARIN™ FE 1/20, SHAROBEL™、DEB....
2013-12-25
The Second Successful US FDA cGMP Inspection with ZERO 483 Observations
The Second Successful US FDA cGMP Inspection with ZERO 483 Observations occurred from March 25 to March 29, 2013.
2013-04-02
Five More Products are Approved by US FDA
Five NOVAST products (WERA™, FALMINA™, ELINEST™, MONO-LINYAH™ and TRI-LINYAH™) receive app....
2012-12-25
Tel:+86(513)-8598 8888
Copyright 2022 by NOVAST
